Hepatitis C virus genotype 4 in Ugandan children and their mothers

Area of Science:

• Hepatology
• Virology
• Public Health

Background:

• Hepatitis C virus (HCV) infection is a significant global health concern.
• Understanding HCV prevalence in African populations is crucial for targeted interventions.
• Pediatric HCV infection and transmission routes require further investigation.

Purpose of the Study:

• To determine the seroprevalence of hepatitis C virus antibodies among children and their mothers in Kampala, Uganda.
• To investigate the confirmation rate of initial antibody-positive results using molecular methods.
• To identify the predominant hepatitis C virus genotype in the studied population.

Main Methods:

• Cross-sectional serological survey conducted in Kampala, Uganda in 2001.
• Hepatitis C virus antibody testing performed on blood samples from children and mothers.
• Reverse transcription-polymerase chain reaction (RT-PCR) used for confirmation of positive antibody results.
• Sequencing of viral RNA to determine hepatitis C virus genotype.

Main Results:

• Hepatitis C virus antibodies were found in 4% of children (27/603) and 12% of mothers (62/525).
• Only about 10% of initial antibody-positive results were confirmed by RT-PCR, indicating a high rate of false positives or rapid viral clearance.
• All successfully sequenced hepatitis C virus samples belonged to genotype 4.

Conclusions:

• The initial seroprevalence of hepatitis C virus antibodies in Kampala children and mothers was relatively low but warrants attention.
• The high discrepancy between antibody screening and PCR confirmation highlights challenges in diagnosing active HCV infection and suggests potential for viral clearance or frequent false-positive antibody results.
• Hepatitis C virus genotype 4 appears to be the predominant strain in this Ugandan population.